Mingxing Hu

1.3k total citations · 1 hit paper
47 papers, 983 citations indexed

About

Mingxing Hu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mingxing Hu has authored 47 papers receiving a total of 983 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Mingxing Hu's work include Protein Degradation and Inhibitors (6 papers), MicroRNA in disease regulation (5 papers) and Pomegranate: compositions and health benefits (5 papers). Mingxing Hu is often cited by papers focused on Protein Degradation and Inhibitors (6 papers), MicroRNA in disease regulation (5 papers) and Pomegranate: compositions and health benefits (5 papers). Mingxing Hu collaborates with scholars based in China, United States and South Korea. Mingxing Hu's co-authors include Yongmei Xie, Tinghong Ye, Youling Gong, Yuanwei Chen, Qiang Fu, Yang Yu, Wenzhen Li, Yijie Wang, Lei Fan and Jun He and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Organic Letters.

In The Last Decade

Mingxing Hu

44 papers receiving 968 citations

Hit Papers

An overview of PROTACs: a promising drug discovery paradigm 2022 2026 2023 2024 2022 50 100 150

Peers

Mingxing Hu
Mingxing Hu
Citations per year, relative to Mingxing Hu Mingxing Hu (= 1×) peers María Benlloch

Countries citing papers authored by Mingxing Hu

Since Specialization
Citations

This map shows the geographic impact of Mingxing Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxing Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxing Hu more than expected).

Fields of papers citing papers by Mingxing Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxing Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxing Hu. The network helps show where Mingxing Hu may publish in the future.

Co-authorship network of co-authors of Mingxing Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingxing Hu. A scholar is included among the top collaborators of Mingxing Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingxing Hu. Mingxing Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Yang, Yueqi Wang, Mingxing Hu, et al.. (2025). Discovery of Novel LAT1-Targeted PET Tracers from 18 F-Labeled Aromatic Amino Acids via Photocatalyzed 18 F-Fluorination. Journal of Medicinal Chemistry. 68(23). 25171–25185. 2 indexed citations
2.
Yu, Yang, Qian Yao, Dan Song, et al.. (2025). Discovery of degrader for FLT3, GSPT1 and IKZF1/3 proteins merging PROTAC and molecular glue targeting FLT3-ITD mutant acute myeloid leukemia. European Journal of Medicinal Chemistry. 296. 117893–117893. 4 indexed citations
3.
Lan, Bo, Yingying Zhang, Guohui Li, et al.. (2025). Activation of zona incerta gamma-aminobutyric acid-ergic neurons alleviates depression-like and anxiety-like behaviors induced by chronic restraint stress. World Journal of Psychiatry. 15(2). 101807–101807. 2 indexed citations
4.
Tang, Zhe, Mingxing Hu, Gan Ye, et al.. (2025). Design, synthesis, and evaluation of 1,3,4-oxadiazole-based EGFR inhibitors. Bioorganic & Medicinal Chemistry Letters. 127. 130315–130315. 2 indexed citations
5.
Xie, Yang, Lili Pan, Yueqi Wang, et al.. (2025). Automated Synthesis of NET-Targeted PET Tracers [ 18 F]4F-mHPG and [ 18 F]3F-pHPG through Photocatalyzed 18 F-Deoxyfluorination. The Journal of Organic Chemistry. 90(50). 18118–18122. 1 indexed citations
6.
Wang, Yueqi, Lili Pan, Mingxing Hu, et al.. (2025). Photocatalyzed 18F-Fluorination: A Streamlined Radiolabeling Approach for Rapid Adoption and Automation. Organic Letters. 27(26). 7224–7229. 4 indexed citations
7.
Hu, Mingxing, Hui Jie, Yujue Li, et al.. (2024). Discovery of orally bioavailable ALK PROTACs based ceritinib against ALK positive cancers. European Journal of Medicinal Chemistry. 279. 116827–116827. 4 indexed citations
8.
Li, Ting, Lu Yu, Mingxing Hu, et al.. (2024). Selective degradation of hyperphosphorylated tau by proteolysis-targeting chimeras ameliorates cognitive function in Alzheimer’s disease model mice. Frontiers in Pharmacology. 15. 1351792–1351792. 12 indexed citations
9.
Zhang, Ruiming, Mingxing Hu, Xingxing Wang, et al.. (2024). Synthesis and biological evaluation of the novel chrysin prodrug for non-alcoholic fatty liver disease treatment. Frontiers in Pharmacology. 15. 1336232–1336232. 5 indexed citations
10.
Li, Yujue, Mingxing Hu, Jinwei Xie, Shuang‐Qing Li, & Lunzhi Dai. (2023). Dysregulation of histone modifications in bone marrow mesenchymal stem cells during skeletal ageing: roles and therapeutic prospects. Stem Cell Research & Therapy. 14(1). 166–166. 15 indexed citations
11.
Zi, Liu, Mingxing Hu, Yang Yu, et al.. (2022). An overview of PROTACs: a promising drug discovery paradigm. Molecular Biomedicine. 3(1). 46–46. 178 indexed citations breakdown →
12.
He, Tao, Mingxing Hu, Shunyao Zhu, et al.. (2022). A tactical nanomissile mobilizing antitumor immunity enables neoadjuvant chemo-immunotherapy to minimize postsurgical tumor metastasis and recurrence. Acta Pharmaceutica Sinica B. 13(2). 804–818. 17 indexed citations
13.
Yang, Chao, Anjie Xia, Mingxing Hu, et al.. (2022). Discovery of highly potent and selective 7-ethyl-10-hydroxycamptothecin-glucose conjugates as potential anti-colorectal cancer agents. Frontiers in Pharmacology. 13. 1014854–1014854. 7 indexed citations
14.
Hu, Mingxing, et al.. (2020). LncRNA HOTAIR knockdown inhibits glycolysis by regulating miR-130a-3p/HIF1A in hepatocellular carcinoma under hypoxia. Biomedicine & Pharmacotherapy. 125. 109703–109703. 54 indexed citations
15.
Wang, Yijie, Jun He, Mingxing Hu, et al.. (2018). An overview of Sirtuins as potential therapeutic target: Structure, function and modulators. European Journal of Medicinal Chemistry. 161. 48–77. 156 indexed citations
16.
Fu, Qiang, Xu Zhang, Yuzhu Wang, et al.. (2018). Glucocorticoid receptor regulates expression of microRNA-22 and downstream signaling pathway in apoptosis of pancreatic acinar cells. World Journal of Gastroenterology. 24(45). 5120–5130. 10 indexed citations
17.
Yue, Ling, Tao Wang, Jingyi Wang, et al.. (2018). Asymmetry of Hippocampus and Amygdala Defect in Subjective Cognitive Decline Among the Community Dwelling Chinese. Frontiers in Psychiatry. 9. 226–226. 76 indexed citations
18.
Li, Yali, Fangfang Yang, Weidong Zheng, et al.. (2016). Punica granatum (pomegranate) leaves extract induces apoptosis through mitochondrial intrinsic pathway and inhibits migration and invasion in non-small cell lung cancer in vitro. Biomedicine & Pharmacotherapy. 80. 227–235. 78 indexed citations
19.
Fu, Qiang, Hongwei Zhang, Tao Qin, et al.. (2013). The influence of microRNA-92b on apoptosis of pancreatitic acinus cells in rats with acute pancreatitis. Zhonghua shiyan waike zazhi. 30(8). 1672–1675. 1 indexed citations
20.
Zhang, Hongwei, Tao Qin, & Mingxing Hu. (2009). Protective effect of IκBα mutant on the acutep ancreatitis in rats. Zhonghua shiyan waike zazhi. 26(1). 61–63. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026